HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marianne Amalric Selected Research

Glutamic Acid (Glutamate)

2/2015Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
4/2012A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
9/2008Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
9/2003Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marianne Amalric Research Topics

Disease

23Parkinson Disease (Parkinson's Disease)
11/2021 - 01/2002
9Catalepsy
01/2015 - 07/2002
4Parkinsonian Disorders (Parkinsonism)
10/2015 - 07/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 07/2002
2Cognitive Dysfunction
01/2019 - 08/2011
2Dyskinesias (Dyskinesia)
02/2015 - 10/2014
1Neurobehavioral Manifestations
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Movement Disorders (Movement Disorder)
01/2016
1Hypokinesia (Bradykinesia)
01/2016
1Brain Diseases (Brain Disorder)
04/2012

Drug/Important Bio-Agent (IBA)

9Haloperidol (Haldol)FDA LinkGeneric
01/2015 - 07/2002
6Dopamine (Intropin)FDA LinkGeneric
11/2021 - 02/2009
6Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2015 - 07/2002
6Levodopa (L Dopa)FDA LinkGeneric
02/2015 - 11/2006
5Oxidopamine (6 Hydroxydopamine)IBA
01/2016 - 07/2002
4Cholinergic Agents (Cholinergics)IBA
01/2021 - 10/2015
4Glutamic Acid (Glutamate)FDA Link
02/2015 - 09/2003
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019 - 01/2016
2Adenosine (Adenocard)FDA LinkGeneric
02/2012 - 09/2008
21-aminocyclopentane-1,3,4-tricarboxylic acidIBA
09/2008 - 06/2007
2Metabotropic Glutamate 5 ReceptorIBA
12/2005 - 07/2002
1telenzepineIBA
01/2016
1TropicamideFDA LinkGeneric
01/2016
1Halorhodopsins (Halorhodopsin)IBA
01/2016
1Muscarinic M4 ReceptorIBA
01/2016
1Cholinergic Antagonists (Anticholinergics)IBA
10/2015
1Bee Venoms (Bee Venom)IBA
01/2015
1Cocaine (Cocaine HCl)IBA
10/2014
1Potassium Channels (Potassium Channel)IBA
08/2014
12- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
02/2012
1N-(3-chlorophenyl)picolinamideIBA
02/2012
1LSP1 2111IBA
10/2009
1metabotropic glutamate receptor 4IBA
10/2009
1Dopamine Agents (Dopaminergic Agents)IBA
09/2008
1Adenosine A2 Receptor AntagonistsIBA
09/2008
1Piribedil (Trivastal)IBA
11/2006
1Dopamine Agonists (Dopamine Agonist)IBA
11/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2005
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
08/2004
1ApomorphineFDA Link
08/2003
1Antipsychotic Agents (Antipsychotics)IBA
08/2003
1metabotropic glutamate receptor type 1IBA
07/2002
1Therapeutic UsesIBA
01/2002

Therapy/Procedure

3Therapeutics
02/2015 - 11/2006
1Palliative Care (Palliative Therapy)
10/2009
1Denervation
12/2005